Invention Grant
- Patent Title: Anti-FGFR2 antibodies
- Patent Title (中): 抗FGFR2抗体
-
Application No.: US13105521Application Date: 2011-05-11
-
Publication No.: US08481688B2Publication Date: 2013-07-09
- Inventor: Zhigang Weng , William M. Winston, Jr. , Ailin Bai , Kristan Meetze , Solly Weiler , Ting Chen , Jeno Gyuris
- Applicant: Zhigang Weng , William M. Winston, Jr. , Ailin Bai , Kristan Meetze , Solly Weiler , Ting Chen , Jeno Gyuris
- Applicant Address: US MA Cambridge
- Assignee: AVEO Pharmaceuticals, Inc.
- Current Assignee: AVEO Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Goodwin Procter LLP
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
Monoclonal antibodies that bind and inhibit biological activities of human FGFR2 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation or overexpression of FGFR2.
Public/Granted literature
- US20110305687A1 ANTI-FGFR2 ANTIBODIES Public/Granted day:2011-12-15
Information query
